Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4508
Gene Symbol: ATP6
ATP6
0.010 GeneticVariation disease BEFREE Five of them harbored mtDNA deletions associated with Kearns-Sayre syndrome (KSS), one had a mitochondrial point mutation at the mtDNA ATPase6 gene, and one had a POLG mutation. 29974349 2018
Entrez Id: 4509
Gene Symbol: ATP8
ATP8
0.300 GeneticVariation disease ORPHANET
Entrez Id: 6314
Gene Symbol: ATXN7
ATXN7
0.010 Biomarker disease BEFREE We present a pediatric patient with 13 and 70 trinucleotide CAG repeats within SCA7 gene and no family history, whose presentation mimicked Kearns-Sayre syndrome (KSS). 17720198 2008
Entrez Id: 793
Gene Symbol: CALB1
CALB1
0.010 Biomarker disease BEFREE To gain further insight into the pathogenesis of cerebellar dysfunction in KSS, antibodies against synaptophysin (SY) were used to identify presynaptic terminals and antibodies to calbindin D (CB) to identify Purkinje cells in the cerebellar cortex and in the dentate nucleus from two autopsied cases of KSS. 10465502 1999
Entrez Id: 56997
Gene Symbol: COQ8A
COQ8A
0.010 GeneticVariation disease BEFREE Cerebellar ataxia is common in myoclonic epilepsy with ragged red fibers (MERFF) due to mutations in the mitochondrial transfer RNA (tRNA) lysine gene, in Kearns-Sayre syndrome due to mtDNA deletions, in sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) due to nuclear POLG1 gene mutations, and also in ARCA2, Friedreich's ataxia, SPG7, SCA28 and autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) due to mutations in nuclear genes involved in mitochondrial morphology or function. 27476418 2017
Entrez Id: 4519
Gene Symbol: CYTB
CYTB
0.010 GeneticVariation disease BEFREE Mitochondrial cytochrome b gene deletion in Kearns-Sayre syndrome associated with a subclinical type of peripheral neuropathy. 9832255 1999
Entrez Id: 2671
Gene Symbol: GFER
GFER
0.010 Biomarker disease BEFREE At follow-up, HSS was to 89.7 in the FuZion® group and 89.0 in the standard group, KSS (clinical) was 92.6 in and 91.3 respectively, and KSS (Functional) was 91.0 in the FuZion® group and 87.6 in the standard group. 30280217 2019
Entrez Id: 2688
Gene Symbol: GH1
GH1
0.010 Biomarker disease BEFREE We found a case of KSS, who initially presented endocrinological dysfunction such as insulin-dependent diabetes mellitus (IDDM) and growth hormone (GH) deficiency, and had not developed external ophthalmoplegia until the age of 17. 9667787 1998
Entrez Id: 2697
Gene Symbol: GJA1
GJA1
0.010 Biomarker disease BEFREE At follow-up, HSS was to 89.7 in the FuZion® group and 89.0 in the standard group, KSS (clinical) was 92.6 in and 91.3 respectively, and KSS (Functional) was 91.0 in the FuZion® group and 87.6 in the standard group. 30280217 2019
Entrez Id: 3552
Gene Symbol: IL1A
IL1A
0.300 Biomarker disease CTD_human Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. 7979221 1994
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.300 Biomarker disease CTD_human Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers. 7979221 1994
Entrez Id: 4015
Gene Symbol: LOX
LOX
0.010 Biomarker disease BEFREE Treatment with the specific LOX inhibitor beta-aminopropionitrile decreased the contraction difference between KSS and normal human fibroblast equivalents. 19661442 2009
Entrez Id: 4099
Gene Symbol: MAG
MAG
0.010 Biomarker disease BEFREE In a Kearns-Sayre syndrome MAG loss region, high levels of mtDNA deletions together with cytochrome- c oxidase-deficient cells and loss of mitochondrial respiratory chain subunits (more prominent in the white than gray matter and glia than axons) confirmed the pathogenicity of mtDNA deletions. 22491194 2012
Entrez Id: 80025
Gene Symbol: PANK2
PANK2
0.010 Biomarker disease BEFREE At follow-up, HSS was to 89.7 in the FuZion® group and 89.0 in the standard group, KSS (clinical) was 92.6 in and 91.3 respectively, and KSS (Functional) was 91.0 in the FuZion® group and 87.6 in the standard group. 30280217 2019
Entrez Id: 5225
Gene Symbol: PGC
PGC
0.010 Biomarker disease BEFREE Besides demonstrating remarkable similarities in the lesion profile of KSS and FL-PGC-1a-deficient mice, this study first provides morphological evidence for the identical origin of WM and GM vacuolation as well as for the presence of intracytoplasmic oligodendroglial vacuoles in mitochondriopathies. 27179217 2016
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.040 GeneticVariation disease BEFREE Our genetic and metabolomics analyses suggest that CAFSA is a heterogeneous entity related to mitochondrial DNA alterations either through POLG mutations or a mechanism similar to what is observed in Kearns-Sayre syndrome. 29423831 2018
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.040 Biomarker disease BEFREE These predominant breakpoint regions are similar to those described in other conditions with multiple deletions, such as autosomal dominant progressive external ophthalmoplegia (adPEO) and normal aging, but different from those described in diseases due to single deletions such as Kearns-Sayre syndrome and sporadic PEO. 9375854 1997
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.040 GeneticVariation disease BEFREE Cerebellar ataxia is common in myoclonic epilepsy with ragged red fibers (MERFF) due to mutations in the mitochondrial transfer RNA (tRNA) lysine gene, in Kearns-Sayre syndrome due to mtDNA deletions, in sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) due to nuclear POLG1 gene mutations, and also in ARCA2, Friedreich's ataxia, SPG7, SCA28 and autosomal-recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) due to mutations in nuclear genes involved in mitochondrial morphology or function. 27476418 2017
Entrez Id: 5428
Gene Symbol: POLG
POLG
0.040 GeneticVariation disease BEFREE Kearns -Sayre syndrome (KSS) is a multisystem disorder with PEO, cardiac conduction block, and pigmentary retinopathy. 29310369 2017
Entrez Id: 10891
Gene Symbol: PPARGC1A
PPARGC1A
0.010 Biomarker disease BEFREE Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy. 27179217 2016
Entrez Id: 24148
Gene Symbol: PRPF6
PRPF6
0.010 AlteredExpression disease BEFREE Finally, the transcription of the nuclear ATPsyn.beta and ANT1 genes was induced in parallel with the high level of mtDNA transcripts in MERRF and MELAS muscle, but was repressed in KSS muscle. 8505336 1993
Entrez Id: 50484
Gene Symbol: RRM2B
RRM2B
0.310 GermlineCausalMutation disease ORPHANET To report the RRM2B mutation frequency in adults with multiple mtDNA deletions and examine RNR assembly in a patient with Kearns-Sayre syndrome (KSS) caused by two novel RRM2B mutations. 21378381 2011
Entrez Id: 50484
Gene Symbol: RRM2B
RRM2B
0.310 GeneticVariation disease BEFREE To report the RRM2B mutation frequency in adults with multiple mtDNA deletions and examine RNR assembly in a patient with Kearns-Sayre syndrome (KSS) caused by two novel RRM2B mutations. 21378381 2011
Entrez Id: 6448
Gene Symbol: SGSH
SGSH
0.010 Biomarker disease BEFREE At follow-up, HSS was to 89.7 in the FuZion® group and 89.0 in the standard group, KSS (clinical) was 92.6 in and 91.3 respectively, and KSS (Functional) was 91.0 in the FuZion® group and 87.6 in the standard group. 30280217 2019
Entrez Id: 291
Gene Symbol: SLC25A4
SLC25A4
0.010 AlteredExpression disease BEFREE Finally, the transcription of the nuclear ATPsyn.beta and ANT1 genes was induced in parallel with the high level of mtDNA transcripts in MERRF and MELAS muscle, but was repressed in KSS muscle. 8505336 1993